Search results for: Market Access
Filter search results
OHE Lunchtime Seminar with Andrea Manca: Economic Evaluation for Decision-making and the Value of Access to Individual Patient Data
16 January 2017
…access to individual patient data. Professor Andrea Manca from the University of York will lead an OHE Lunchtime Seminar on 13th February 2017 on the topic of economic evaluation for…
Assessing Value, Budget Impact and Affordability to Inform Discussions on Access and Reimbursement: Principles and Practice, with Special Reference to High Cost Technologies
1 April 2017
…Affordability to Inform Discussions on Access and Reimbursement: Principles and Practice, with Special… The 2016 meeting of the HTAi Asia Policy Forum meeting was held in Kuala Lumpur, 17th -18th…
Around The World in HTAs: Türkiye – The bumpy road toward transformation
31 January 2024
…Another way to access the market is the Named Patient Program (NPP), which was formulated as an exceptional way of reaching the market. Accordingly, medicines that the TMMDA has yet…
How Much Should Society Pay for a New Orphan Drug? A Contribution to this Debate is now Available in a New OHE Research Paper
18 July 2018
…(OMPs) in the United Kingdom and other European Countries. OHE Consulting Report. OHE Consulting Ltd. Available at: https://www.ohe.org/publications/comparing-access-orphan-medicinal-products-omps-united-kingdom-and-other-european [last accessed: 16 July, 2018] Towse, A. and Garau, M. (2018). Appraising…
Spotlight on OHE: Assessing Value and Balancing Needs in Health Care
15 December 2011
…Patient Access Schemes, Flexible Pricing Schemes and risk sharing schemes, all of which are becoming increasingly common approaches to shaping access to new drugs. Value based pricing (VBP), due to…
Estimating US Savings from Biosimilars
13 July 2010
…approved in mid-2006, has gained only 2% market share despite being priced 25% below the market. Avalere found that payers are not pushing physicians to prescribe cheaper therapeutic alternative human…
NHS Agency Staffing and the Impact of Recent Interventions
1 January 2018
This seminar focuses on the NHS staffing markets and the use of temporary staff, specifically in the NHS provider sector, i.e. foundation trusts and NHS trust. (which include hospitals). To…
OHE Lunchtime Seminar: Price Regulation of Generics and Drug Shortages
27 November 2018, 12:00am
…is set to high, the drug plans overpay. Conversely, when the MALP is set too low, firms either don’t enter the market, or exit the market often creating drug shortages….
OHE Lunchtime Seminar: Price Regulation of Generics and Drug Shortages
8 November 2018
…firms either don’t enter the market, or exit the market often creating drug shortages. Drug shortages are an increasing concern in Canada and globally and it has been argued that…